longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

HEALTHYWAY INC

02587

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 11.76, within the reasonable range, cheaper than 45.59% of the time in the past 1 years, and the industry ranks 6/30, the industry Median 8.67.

11.76xP/E
HK$0.90Stock price
HK$0.08Earnings per share
11.76xP/E
Stock priceHK$0.90Earnings per shareHK$0.08

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-17.19x
Typical range
-21.27x–41.27x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 8.67x
0275481108

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 8.67x
0x30x60x90x120x150x
P/E ratio
Name/Symbol
02666HKUNI MEDICAL
3.67x6.04%HK$9.27B
02273HKGUSHENGTANG
12.37x33.65%HK$6.01B
02587HKHEALTHYWAY INC
11.76x--HK$782.47M
02159HKMEDIWELCOME
14.61x--HK$572.02M
01419HKHUMAN HEALTH
10.39x--HK$288.46M
02325HKYUNKANG GROUP
4.04x--HK$282.67M
02293HKBAMBOOSHEALTH
8.67x--HK$144.89M
00648HKSOFTMEDX
6.69x--HK$55.17M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.